THY1 and arthritic joint disease: In a murine model of arthritis, specific depletion of FAPα+THY1+ FLS led to inflammation decrease, whereas depletion of THY1− FLS resulted in bone protection, suggesting that these cell subtypes are putative therapeutic targets [6].